CVIHIGH SIGNALFINANCIAL10-K

CVI experienced a substantial deterioration in operating cash flow generation alongside a significant reduction in cash reserves and overall asset base.

The dramatic decline in operating cash flow combined with the substantial reduction in cash reserves signals potential operational challenges or cyclical pressures in CVI's refining operations. The company appears to have used cash reserves to manage working capital needs and possibly reduce debt obligations, which could limit financial flexibility going forward.

Comparing 2026-02-18 vs 2025-02-19View on EDGAR →
FINANCIAL ANALYSIS

CVI's financial position weakened notably during the period, with operating cash flow declining substantially while interest expenses rose meaningfully due to higher rates or debt service costs. The company's balance sheet contracted across most categories, with cash reserves dropping significantly, current assets declining materially, and total assets shrinking over 13%. However, the company did reduce both current liabilities and total debt, suggesting some deleveraging efforts, though this came at the cost of depleted cash reserves and reduced operational cash generation.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-64.4%
$404.0M$144.0M

Operating cash flow fell 64.4% — earnings quality concerns; investigate working capital changes and non-cash items.

Cash & Equivalents
Balance Sheet
-48.2%
$987.0M$511.0M

Cash declined 48.2% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Current Liabilities
Balance Sheet
-35.7%
$1.1B$706.0M

Current liabilities reduced — improved short-term financial position and working capital health.

Interest Expense
P&L
+31.2%
$83.9M$110.1M

Interest expense surged 31.2% — significant debt increase or rising rates materially impacting earnings.

Current Assets
Balance Sheet
-30.5%
$1.8B$1.3B

Current assets declined 30.5% — monitor working capital adequacy and short-term liquidity.

Accounts Receivable
Balance Sheet
-20.3%
$295.0M$235.0M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Total Assets
Balance Sheet
-13.1%
$4.3B$3.7B

Total assets contracted 13.1% — asset sales, write-downs, or balance sheet optimization underway.

Total Debt
Balance Sheet
-10.5%
$1.9B$1.7B

Debt reduced 10.5% — deleveraging strengthens balance sheet and reduces financial risk.

LANGUAGE CHANGES
NEW — 2026-02-18
PRIOR — 2025-02-19
ADDED
As of February 13, 2026, there were 100,530,599 shares of the registrant s common stock outsta nding.
Directors, Executive Officers and Corporate Governance 118 Item 1A.
Management's Discussion and Analysis of Financial Condition and Results of Operations 46 Item 7A.
Renewable Volume Obligation ( RVO ) A requirement set by the United States Environmental Protection Agency that determines how much renewable fuel a refiner must blend in a given year.
Vegetable oil An oil extracted from plants, such as canola, corn, and soybean, that can be processed into renewable fuels, including diesel, jet, naphtha, and other fuels.
+7 more — sign up free →
REMOVED
As of February 14, 2025, there were 100,530,599 shares of the registrant s common stock outsta nding.
Directors, Executive Officers and Corporate Governance 127 Item 1A.
Management's Discussion and Analysis of Financial Condition and Results of Operations 48 Item 7A.
Utilization Measurement of the annual production of UAN and ammonia expressed as a percentage of each facilities nameplate production capacity.
All statements other than statements of historical fact, including without limitation, statements regarding future operations, financial position, estimated revenues and losses, growth, capital projects, stock or unit repurchases, impacts of legal proceedings, projected costs, prospects, plans and objectives of management are forward-looking statements.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →